Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Century Therapeutics (IPSC) Interest Expenses (2022 - 2023)

Century Therapeutics (IPSC) has disclosed Interest Expenses for 2 consecutive years, with $136000.0 as the latest value for Q2 2023.

  • Quarterly Interest Expenses fell 46.46% to $136000.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $136000.0 through Mar 2024, down 91.59% year-over-year, with the annual reading at $540000.0 for FY2023, 62.24% down from the prior year.
  • Interest Expenses for Q2 2023 was $136000.0 at Century Therapeutics, down from $348000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $643000.0 in Q4 2022, with the low at $136000.0 in Q2 2023.